Introduction
It has long been known that during peritoneal dialysis there is a considerable loss of protein, which consists mainly of albumin and IgG (Berlyne et al., 1964) . This protein loss in dialysate fluid during 24 hr on peritoneal dialysis is usually in the range of 20-60 g/day. Simultaneously, amino acid losses per 24 hr of peritoneal dialysis are of the order of 13g /45 litre dialysis exchange (Berlyne et al., 1967) .
These losses of amino acids and protein, especially albumin, must result in impaired synthesis of plasma proteins and an increase in patient morbidity due to, firstly malnutrition (Schaeffer et al., 1975) and, secondly, infection (Bistrian, 1977) . Hypoproteinaemia is a frequent finding after peritoneal dialysis.
It was decided to investigate whether it was possible to obviate such complications in patients by the addition of amino acids to peritoneal dialysis fluid as suggested by Gjessing, 1968 The amino acids analysed were glutamic acid, proline, glycine, alanine, valine, methionine, isoleucine, leucine, tyrosine, phenylalanine, histidine and arginine. There were separation difficulties with lysine, threonine and tryptophan at the time of this study. Since the volume of dialysis fluid infused, the volume of dialysate fluid removed from the peritoneal cavity, and the concentration of amino acids in both solutions were known it was possible to calculate an amino acid balance.
Results
Details of the patients studied and the changes in their total serum protein, albumin, complement (C3) and transferrin during peritoneal dialysis are shown in Table 1 . The serum protein comparisons between the control and amino acid supplemented peritoneal dialysis are shown in Table 2 and no statistically significant differences were seen although the downward trend was less in the treated group for total serum protein, serum albumin and serum globulin. Table 3 shows the amino acid balance results. The patients who had 10 ml of Vamin-glucose added to their dialysis fluid were all in strongly positive Dialysis fluid* with supplement n = 8 -6-1 (6 3) balance for glutamic acid, proline, valine, methionine isoleucine, leucine, phenylalanine and arginine. These were the amino acids which in the supplemented dialysis fluid were relatively more concentrated in comparison to plasma values. The balances for these amino acids were positive in all the patients even when they were having excess fluid taken off by the use of hypertonic dialysis solution. Conversely, glycine and alanine, which are in the same concentration, and tyrosine in lower concentration in the supplemented dialysis fluid than in normal plasma, resulted occasionally in a negative balance for these amino acids. The individual plasma amino acid concentrations before and after peritoneal dialysis in control and treated groups did not show any significant changes. These results suggest that aminoacid fluxes are dependent upon simple diffusion gradients and that absorption of amino acids from the peritoneal dialysate is by simple diffusion.
Histidine, which was not measured in all patients, gave varying results and in D.J., in particular, there was an apparent negative histidine balance. However, further evaluation of the technique has revealed that 3-methylhistidine (3-MH), a non recyclable metabolite of muscle tissue (Long et al., 1975) , and histidine appeared in the same peak. This problem has been noted previously (Condon and Asatoor, 1971) . Probably any apparently high histidine peak in the present method must contain 3-MH which indicates a catabolism of the patient.
Discussion
The results for the amino acids other than histidine suggest that the method of absorption is by simple diffusion across the peritoneal membrane. The more concentrated the amino acid in the dialysis fluid in relation to the plasma concentration the more positive the balance for that amino acid. If this mechanism is the same for lysine, threonine and tryptophan which they did not measure, and there is no reason for believing otherwise, the authors would anticipate that the balance for these amino acids using Vamin-glucose would also be positive.
There was no statistically significant difference in the plasma amino acid profiles at the beginning and end of peritoneal dialysis or between those patients receiving supplemented dialysis solution and those who did not. Therefore, it may be concluded that measurement of actual amino acid losses is the optimal way of assessing amino acid nitrogen losses, that additions of Vamin-glucose do not cause aberrations of the amino acid profile so as to cause toxicological effects and that the plasma amino acid concentrations, since they represent less than 1% of the total amino acid pool, are a poor marker of amino acid metabolism (Bergstrom et al., 1972) .
During haemodialysis amino acid losses of 2-3 g/hr occur (Schaeffer et al., 1975 It can be seen from the 2 control patients ( Table 3) that there were marked losses of proline, glutamic acid, cystine, glycine, alanine, leucine, isoleucine, phenylalanine, tyrosine, histidine and arginine. These findings are in accordance with those of Berlyne et al. (1967) . However, low concentrations of methionine were found in the dialysate fluid of the present patients whereas Berlyne et al. (1967) found high concentrations of dialysate methionine as their patients were on dietary methionine supplements.
Since the half-life of albumin is about 16 days it is not surprising that there were no statistically significant changes in serum albumin between the patients who had Vamin-glucose-supplemented dialysis fluid and the patients who did not. Table 2 demonstrates the problems of using complement (C3) and transferrin as markers of nutritional adequacy (Hill et al., 1977; Silk, 1978) . Patient J.R. had an immune complex-mediated glomerulonephritis which is associated with low concentrations of complement C3. Patient M.B. had a small haemorrhage into the peritoneal cavity at the start of peritoneal dialysis and this was associated with a very large fall in serum transferrin. Since many factors affect serum transferrin and complement C3 concentrations in renal disease it might be anticipated that no significant difference would be found between the Vamin-glucose supplemented and the control group.
Currently there is not a good discriminator of rapid change in nutritional status or immune competence to use in such patients and it would be necessary to follow-up these patients for several weeks after peritoneal dialysis and then re-assess their nutritional status. The authors' approach prevents amino acid losses from the amino acid pool which implies that albumin and immunoglobulins will be re-synthetized more rapidly than if the amino acid pool is depleted.
During this work and subsequent observations with Vamin glucose-supplemented dialyses the authors have not noted local or systemic adverse reactions to the amino acid solution. Since the regimen of adding Vamin-glucose to dialysis fluid was started they have not had any cases of infection in the peritoneal cavity.
